期刊文献+

系统性红斑狼疮患者发生静脉血栓栓塞事件的风险 被引量:6

Risk of venous thromboembolism in patients with systemic lupus erythematosus
下载PDF
导出
摘要 系统性红斑狼疮患者发生静脉血栓(venous thromboembolism,VTE)事件,包括肺栓塞(pulmonary embolism,PE)和深静脉血栓(deep vein thrombosis,DVT)的风险显著增加。其病因及发病机制相当复杂,除原发病疾病活动因素外,还涉及抗磷脂抗体、低白蛋白血症、高球蛋白血症、长期应用糖皮质激素所导致的糖、脂代谢异常、肥胖等。至今,国内外文献尚未针对SLE患者发生VTE的危险因素进行全面系统性分析,本文将对SLE发生静脉血栓栓塞事件的相关研究进展做一综述。 The risk of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is significantly increased in patients with systemic lupus erythematosus. Its etiology and pathogenesis are quite complicated, involved with the disease activities, antiphospholipid antibodies, hypoproteinemia, hyperglobulinemia and glyeolipid metabolism disorders caused by long-term application of glucocorticoids. The risk factors of VTE in lupus patients were hardly analyzed before in literatures. The progress in research of VTE events in lupus patients was reviewed in this article.
作者 尤含笑 赵久良 孙伊多 李梦涛 曾小峰 YOU Han-xiao;ZHAO Jiuliang;SUN Yiduo;LI Meng-tao;ZENG Xiao-feng(Department of Rheumatology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China)
出处 《中华临床免疫和变态反应杂志》 2019年第3期226-231,共6页 Chinese Journal of Allergy & Clinical Immunology
关键词 系统性红斑狼疮 静脉血栓栓塞 抗磷脂抗体 肺栓塞 深静脉血栓 Systemic lupus erythematosus Venous thromboembolism Antiphospholipid antibody Pulmonary embolism Deep venous thrombosis
  • 相关文献

参考文献1

二级参考文献22

  • 1Miyakis S, Loekshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [ J ]. J Thromb Haemost, 2006,4(2) :295-306.
  • 2Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1997,40 (9) : 1725.
  • 3Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjtgren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [ J] . Ann Rheum Dis, 2002,61 (6) :554-558.
  • 4Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[ J ]. Arthritis Rheum, 1988,31 ( 3 ) : 315- 324.
  • 5Meneghel L, Ruffatti A, Gavasso S, et al. Detection of IgG anti- Domain I beta2 Glycoprotein I antibodies by chemil immunoassay in primary antiphosphohpld syndrome [ J ]. 11n Chim Acta, 2015,446:201-205.
  • 6Willis R, Grossi C, Orietta BM, et al. International standards for IgG and IgM anti-[32glyeoprotein antibody measurement [ J ]. Lupus ,2014,23 ( 12 ) : 1317-1319.
  • 7Pengo V. ISTH guidelines on lupus anticoagulant testing [ J ]. Thromb Res, 2012,130 Suppl 1 :$76-77.
  • 8Fujieda Y, Atsumi T, Amengual O, et al. Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome [ J ]. Lupus, 2012,21 ( 14 ) : 1506- 1514.
  • 9Sciascia S, Murru V, Sanna G, et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus : evaluation of 23 possible combinations of antiphospholipid antibody specificities [ J ]. J Thromb Haemost, 2012,10(12) :2512-2518.
  • 10Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study [J]. Blood, 2011,118(17) :4714-4718.

共引文献29

同被引文献43

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部